ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

June 25, 1982

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995

In Brief: King Named To Replace Saunders; Zubrod Retires, Will Go To Miami; Perry acting Treatment Chief

June 14, 1974

STAR completes enrollment.

July 30, 2004

Letter: Legal Fund Seeks Support For Fisher

March 3, 1995

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996